Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131931) titled 'An exploratory study on the safety and efficacy of 177Lu-FAP-2286 versus 225Ac-FAP-2286 therapy for FAP-positive advanced pancreatic ductal adenocarcinoma' on Sept. 8.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The affiliated hospital of southwest medical university
Condition:
Pancreatic ductal adenocarcinoma
Intervention:
Experimental group:225Ac-FAP-2286
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-15
Target Sample Size: Experimental group:30;Control group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr...